NIDA Technical Editorial Support Services
Health and Human Services (all) · OMAS STRATEGIC BUYING CENTER - PROFESSIONAL SERVICES
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 7571PS26Q00082 in this department, oldest first.
- Aug 3, 2026 · this noticeCombined Synopsis/Solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The National Institute of Health's Office of National Institute of Drug Abuse (NIDA) is seeking specialized technical editorial support. The Contractor shall provide technical editorial support to the NIDA Intramural Research Program (IRP), Office of the Clinical Director, including manuscript editing and submission support, letters of recommendation, clinical protocols, informed consent materials, standard operating procedures, regulatory-facing documents, and related editorial services. Please see the attached full solicitation and statement of work.
Who won similar work
875 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Health and Human Services (all)), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (806): middle half $78K to $4.9M, median $407K; range $1 to $89.0B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| DT-TRAK CONSULTING, INC. | 15 | $23.1M | Sep 9, 2026 |
| LACREEK DEVELOPMENT CORP | 14 | $24.3M | Aug 5, 2026 |
| LYDAY CONSTRUCTION LLC | 14 | $508K | Sep 2, 2026 |
| BIGHORN RIDGERUNNERS, LLC | 10 | $2.2M | Jul 27, 2026 |
| Prime Physicians Tri Providers LLC | 7 | $110.0M | Sep 22, 2026 |
| RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA | 6 | $1.5B + 1 shared | Oct 5, 2026 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 6 | $967K | Sep 11, 2026 |
| Tywell Builders LLC | 6 | $60K | Jun 10, 2025 |
| POLOLEI SOLUTIONS, LLC | 5 | $3.3M | Jul 21, 2026 |
| ALKO ENTERPRISES INC | 5 | $2.6M | Apr 27, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Oct 19, 2026ADVANCED DRILLING LLC$47KS. DeGoede Well (COW)No listed company matched (Materiality N/A)
- Oct 13, 2026DATIX (USA) INC.$2.2MIHS Agency-wide Instructions for Use Subscription ServicesNo listed company matched (Materiality N/A)
- Oct 9, 2026Revvity Health Sciences, Inc.$21KAutomated Cell Counter and AnalyzerNo listed company matched (Materiality N/A)
- Oct 8, 2026Please_See_Spreadsheet Silver Spring MD 20993 USA$120.8MFY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory ScienceNo listed company matched (Materiality N/A)
- Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026BCG FEDERAL CORP.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026FISHER BIOSERVICES INC$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESMateriality: 0.10% of $TMO revenue (Low) SEC
- Oct 7, 2026SIA PARTNERS U.S., INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026PPD DEVELOPMENT LP$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Health & Human Services, Dept of (HHS) since 2024 (0 filings)
- 0 of their lobbyists list a past Health & Human Services, Dept of (HHS) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 253 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.